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Abstract
Background: The solubility of recombinant proteins expressed in bacteria is often disappointingly
low. Several strategies have been developed to improve the yield and one of the most common
strategies is the fusion of the target protein with a suitable partner. Despite several reports on the
successful use of each of these carriers to increase the solubility of some recombinant proteins,
none of them was always successful and a combinatorial approach seems more efficient to identify
the optimal combination for a specific protein. Therefore, the efficiency of an expression system
critically depends on the speed in the identification of the optimal combination for the suitable
fusion candidate in a screening process. This paper describes a set of expression vectors (pETM)
designed for rapid subcloning, expression and subsequent purification using immobilized metal
affinity chromatography (IMAC).
Results: A single PCR product of two Yellow Fluorescent Proteins (EYFPs) was cloned into 18
vectors comprising identical restriction sites and varying fusion partners as well as differing
protease recognition sites. After a small-scale expression, the yields of the different constructs
were compared using a Coomassie stained SDS-polyacrylamide gel and the results of this
preliminary screening were then confirmed by large-scale purification. The yields were calculated
and the stability of the different constructs determined using three independent conditions. The
results indicated a significant correlation between the length and composition of non-native amino
acid tails and stability. Furthermore, the buffer specificity of TEV and 3C proteases was tested using
fusion proteins differing only in their protease recognition sequence, and a His-GST-EYFP
construct was employed to compare the efficiency of the two alternative affinity purification
methods.
Conclusion: The experiments showed that the set of pETM vectors could be used for the rapid
production of a large array of different constructs with specific yield, stability, and cleavage features.
Their comparison allowed the identification of the optimal constructs to use for the large-scale
expression. We expect that the approach outlined in this paper, i.e. the possibility to obtain in
parallel fusion products of the target protein with different partners for a preliminary evaluation,
would be highly beneficial for all them who are interested in the rapid identification of the optimal
conditions for protein expression.
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Background
Several factors can contribute to poor expression levels or
low yields of soluble recombinant proteins produced in E.
coli [1]: codon bias, lack of post-transcriptional modifica-
tions, incorrect membrane targeting, high protease activ-
ity, missing partners for complex formation, mRNA
instability, limiting redox conditions or chaperone availa-
bility. A large number of modified strains is now commer-
cially available which either exhibit a compensative
expression of rare codons, co-express specific molecular
chaperones, lack protease activity or provide an oxidizing
cytoplasm. Furthermore, polycistronic vectors allow the
co-expression of several complex subunits and fused
leader peptides enable the translocation of ribosomal
products to the oxidizing periplasm. However, the most
common approach to improve the solubility of recom-
binant proteins is their fusion with highly soluble part-
ners.
For instance, NusA has been initially selected for being the
most soluble protein in E. coli [2]. Several other proteins
have been proposed as fusion partners [3] but only few of
them are commonly exploited. Among them, thioredoxin
(Trx) [4], glutathione S-transferase (GST) [5] and maltose
binding protein (MBP) [6] offer the further advantage of
being suitable for affinity purification, whereas DsbA and
DsbC [7,8] are enzymes that facilitate the formation of
disulphide bonds. Furthermore, we showed that ther-
Maps of the pETM vectors Figure 1
Maps of the pETM vectors. The vectors pETM11, 44, and 55 are shown as representative examples of the different variables 
used to combine tags and protease recognition sites.
A) B)
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mostable proteins improve the yields and enable the puri-
fication of the recombinant fusion by simple heat
incubation [9].
Nevertheless, some shortcomings are well documented.
The linker between GST and the target protein is often
instable, leading to the breakage and loss of the target pro-
tein [10,11], whereas the solubility of the fusion protein
does not yet indicate that the target protein is correctly
folded. Soluble aggregates of fusion proteins have been
described for both MBP [12] and GST [13,14].
For several applications, the fusion carriers must be
removed before using the target proteins. Specific protease
recognition sequences are engineered as linkers between
the fusion partners and proteolytic digestion used to
remove the carriers. Among commercially available pro-
teases, TEV [15] and HRV 3C [16] are the most reliable
ones because of their longer recognition site and, conse-
quently, extremely limited non-specific cleavage.
Previous experiments indicate that the optimal conditions
to maximize yields, correct folding, and protease cleavage
efficiency are protein specific. Therefore, a preliminary
screening for the identification of the most suitable
expression conditions for the production of soluble pro-
teins is necessary before moving to large-scale production
[17]. Approaches that allow the parallel cloning in differ-
ent vectors simplify the comparison among fusion part-
ners. In this paper we present the results obtained cloning
a unique PCR product into the pETM expression vectors
developed in our institute.
Results and Discussion
General features of the pETM vectors
The pETM vectors are derived from pET (Novagene) back-
bones. They share some common features, the most
important of which being a 6xHis tag, a protease recogni-
tion site and the conserved multiple cloning site (MCS)
starting with an NcoI recognition site (Fig. 1). The NcoI
recognition sequence has an in-frame ATG codon that can
be used for the functional expression of the target protein,
minimizing the number of non-native amino acids at the
N-terminus. The conserved MCS ensures that the same
couple of restriction sites inserted in the PCR product can
be used for direct subcloning in all of the other pETM vec-
tors.
The 6xHis tag suitable for immobilized metal affinity
chromatography (IMAC) purification and a protease rec-
ognition site, with the exception of the pETM10, are
present in all vectors. Both, the TEV and the 3C recogni-
tion site versions exist for each vector subclass. The vectors
differ in their tag(s) and they are identified by the first
number after the pETM code. In particular, 1 indicates the
class of pETM vectors with only a His-tag, 2 those with
His-tag plus Trx, 3 the combination His-tag and GST (a
complete list of the vector maps is available -see addi-
tional file 1: "The maps of the pETM vectors"- and their
sequences can be downloaded at our website [18]). The
second number identifies the specific version that can dif-
fer from the others because of the protease restriction site,
the relative position of the His-tag at the N or C-terminus
of the fusion partner (Fig. 1B and 1C) and the presence of
a leader peptide for periplasmic targeting (Table 1). A
Table 1: Specific features of the vectors. The vectors used in the experiments have conserved cloning sites but differ in the position 
and identity of the tags and in the protease recognition sequences. Both the EYFP constructs were cloned in all the indicated vectors. 
(italic) functional tag; (italic) purification tag;(bold) double-function tag.
pETM Vectors Composition of the expressed recombinant fusion proteins
10 His-Tag EYFP
11 His-Tag TEV-site EYFP
14 His-Tag C3-site EYFP
20 Trx His-Tag TEV-site EYFP
22 Trx His-Tag C3-site EYFP
30 His-Tag GST TEV-site EYFP
33 His-Tag GST C3-site EYFP
44 His-Tag MBP C3-site EYFP
50 DsbA His-Tag TEV-site EYFP
52 Ll DsbA His-Tag TEV-site EYFP
54 DsbA His-Tag C3-site EYFP
55 Ll DsbA His-Tag C3-site EYFP
60 NusA His-Tag TEV-site EYFP
66 NusA His-Tag C3-site EYFP
70 CBP TEV-site EYFP His-Tag
80 DsbC His-Tag TEV-site EYFP
82 Ll DsbC His-Tag TEV-site EYFPMicrobial Cell Factories 2005, 4:34 http://www.microbialcellfactories.com/content/4/1/34
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stuffer gene has been cloned in some vectors (Figure 1A)
to simplify the evaluation of the restriction enzyme diges-
tion efficiency.
Only pETM20 carries the β-lactamase gene that confers
ampicillin-resistance, whereas all the other vectors are
kanamycin-selectable.
Comparison of the constructs
Two EYFPs (wild type and I48A mutant) were cloned into
the pETM vectors. The specific features of the constructs
used in the analysis are listed in Table 1. The His-tag is
directly fused to the target protein in the pETM10 vector
whereas a TEV and a 3C recognition site is inserted
between the target protein and the tag in vectors pETM11
and 14, respectively. The pETM20 and 22 vectors contain
the stabilising Trx fusion tag [4] and differ only in the pro-
tease restriction site. Cloning into pETM30 and 33 vectors
allows the expression of GST-fusion proteins that can be
purified by two independent and alternative affinity
methods. Also, the MBP-EYFP fusion protein obtained by
cloning into the vector pETM44 can be purified by both,
maltose affinity and IMAC. In the case that the correct
folding of recombinant proteins involves the formation of
disulfide bonds the yield can be improved by fusion with
DsbA and DsbC, both in the cytoplasm [8] or after target-
ing into the oxidizing environment of the periplasm. The
vectors pETM50, 52, 54, 55, 80, and 82 cover all of these
Comparison of the wt and I48A mutant EYFP soluble yields using the different pETM vectors Figure 2
Comparison of the wt and I48A mutant EYFP soluble yields using the different pETM vectors. A) Small-scale affinity purification 
of two EYFPs (wild type and mutant I48A) expressed in BL21(DE3) bacterial cells and using the following vectors: pETM10, 
pETM14, pETM30, pETM11, pETM20, pETM22, pETM33, pETM44, pETM50, pETM52, pETM55, pETM66, pETM80, pETM54, 
pETM60, pETM70, pETM82. B) Small scale affinity purification of constructs expressed by pETM20 under different growth con-
ditions and the alternative bacterial strain BL21(DE3) pLysS. C) Small-scale purification of wt EYFP expressed in pRSET and 
pETM10 vectors. D) Large-scale purification pattern of wt EYFP expressed in pETM11.
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possibilities. The pETM60 and 66 vectors allow the fusion
of the target protein with the highly soluble bacterial
NusA protein [2], and the pETM70 leads to the expression
of fusion proteins with the calmodulin-binding protein.
The yield of soluble EYFP expressed using the commercial
pRSET vector (Invitrogen) was used as a reference. The
crucial features for expression control (origin of replica-
tion, promoter) of pRSET and pETM are the same, but
they differ in the length of the region between the His tag
and target protein.
Small-scale expression screening
Small-scale (1.5 mL) cultures contain enough material for
a rapid comparison of recombinant protein yields. The
bacterial lysates from wild type and mutant EYFP were
analysed by SDS-PAGE and used to estimate the total
expression levels of the recombinant constructs while the
soluble fractions recovered after centrifugation were used
to purify the recombinant proteins by IMAC using Talon
resin. We found this information more reliable than the
analysis of the total soluble fraction in which soluble
aggregates can be highly represented [12-15,19].
All of the vectors expressed recombinant proteins of the
expected molecular mass but the amount of accumulated
recombinant proteins differed among the vectors: GST
fusion>His only>MBP fusion>DsbA fusion>DsbC fusion
= NusA fusion>Trx fusion. Apparently, the expression rate
is dependent on the fusion partner because similar yields
were obtained expressing the fusion partners alone: GST =
MBP>DsbC>DsbA = NusA>Trx (data not shown),
although the regulative expression elements are the same
for all the vectors. Codon bias, mRNA or protein stability
[20] can further influence the level of protein accumula-
tion. For instance, wild type and mutant EYFP expressed
using the same vector often differed for the amount of
accumulated soluble protein (Fig. 2A). The comparative
screening indicated that the mutant EYFP was more solu-
ble than the wild type when expressed from the pETM22
and 33, whilst the wild type when expressed from the
pETM66.
SDS-PAGE analysis of the IMAC purified recombinant
proteins from bacteria transformed with the different vec-
tors is shown in Figure 2A. EYFP depends on a reducing
environment to successfully complete its folding and its
expression in the periplasm was used as a negative con-
trol. As expected, the recombinant proteins secreted in the
periplasm expressed from pETM50, 54, and 80 were
mostly not soluble. A negative effect of the fusion partners
DsbA and DsbC is ruled out since the leaderless versions
of the same vectors (pETM52, 55, and 82) largely accumu-
lated in the soluble fraction.
All of the remaining constructs were soluble, with the
exception of the calmodulin-binding fusion (pETM70).
The amount of purified proteins seemed strongly vector-
dependent but it is necessary to remind that this compar-
ison is rather qualitative because larger constructs (fusions
with MBP or NusA, namely pETM44, 60, and 66) stain
less than constructs with smaller fusions (Trx, GST, DsbA,
and DsbC: pETM20, 22, 30, 33, 52, 55, 82) or no fusion
partners (pETM10, 11, 14).
A second round of screening can be envisaged in which
different expression conditions can be tested in parallel
for their effect on the soluble protein yields. For instance,
the pETM20 vector is the only ampicillin-resistant and has
a different backbone. The constructs from the pETM20
were poorly expressed and gave a low yield of soluble pro-
tein when standard growth conditions were used. The
metabolization of the ampicillin could result in the loss of
selectivity for the transformed bacteria and their substitu-
tion in the liquid culture with wild type cells. Further-
more, a higher level of expression leakage can lead to
mutations of the T7 polymerase, with consequent
decreased transcription functionality and repressed
expression of the recombinant protein [21]. Therefore, the
pETM20-EYFP vector was cultured using the degradation-
resistant carbenicillin instead of ampicillin and either
transformed in pLysS cells or cultured in the presence of
glycerol to prevent expression leakage. As a result, the
yields of the soluble proteins were dramatically increased
(Fig. 2B).
Apparently, even minor differences in the sequence of an
expressed construct can significantly affect the protein sol-
ubility, as in the case of EYFP from pETM11 and pETM14
that differ only in the protease recognition site. We com-
pared two other similar vectors to gain further informa-
tion about the critical features involved in protein
solubility. The EYFP construct from pETM10 accumulated
at higher concentrations than that from pRSET (Fig. 2C,
total lysates). Furthermore, the first construct was appar-
ently soluble because concentrated by the affinity purifi-
cation step while the EYFP expressed from pRSET seemed
mostly insoluble (Fig. 2C). The presence of a long, not
structured region, at the N-terminus of the recombinant
protein expressed by pRSET could explain the different
results because, otherwise, the two vectors share the same
expression regulative features.
The first set of data show that the screening step based on
affinity purification and SDS-PAGE analysis is a reliable
tool for the identification of soluble recombinant protein,
select among constructs expressed from vectors belonging
to the same subclass (for instance, pETM10 and 14 with
respect to 11), the comparison of different growth condi-Microbial Cell Factories 2005, 4:34 http://www.microbialcellfactories.com/content/4/1/34
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tions, and the evaluation of the degradation rate of the
constructs.
Large-scale purifications
The constructs with the wild type EYFP version were puri-
fied from the pellet corresponding to 1 L culture. The
supernatants obtained after lysate ultracentifugation were
loaded onto CoCl2-activated sepharose columns and the
recombinant His-tagged protein was eluted after a wash-
ing step. After desalting the purified protein was used for
stability tests and its concentration calculated according to
its specific absorbance at 280 nm (Table 2). A typical puri-
fication pattern (EYFP from pETM10) is reported in Figure
2D to show that the non-specific binding is negligible
after extensive washing.
The highest yields of EYFP fusions were obtained using
NusA as a stabilizing partner (constructs 60 and 66) but
high yields were also obtained with fusions with both GST
and DsbA (30, 33, 52 and 55) and using the vectors
pETM10 and 14 (only His tag) (Table 2). The yields of
pure EYFP obtained from the pETM10, 14, 60, and 66
become comparable after removal of the carrier proteins.
Trx, DsbA, and DsbC, (pETM20, 22, 52, 55, and 82)
fusions yielded lower amounts of soluble protein, as also
with the pETM11 vector (His tag only). The constructs
expressed from pETM11 and 82 became instable after
incubation at 30°C overnight or after repetitive freezing
and thawing cycles (Table 2). This was in contrast to all of
the other proteins with fusions that remained monodis-
perse after these trials. The large-scale experiments con-
firmed that no soluble protein could be recovered from
bacteria transformed with pETM70 (fusion to calmodu-
lin-binding protein) and vectors expressing constructs for
periplasmic secretion (pETM50, 54, and 80).
In some cases the fusion constructs appeared to be par-
tially cleaved at the level of the linker during the purifica-
tion. Roughly 10% of the protein purified from bacteria
expressing DsbA-EYFP fusions was represented by DsbA
alone. Similarly, we recovered 15% of pure GST from the
GST-EYFP fractions and 35% of DsbC as a degradation
product of the DsbC-EYFP fusion (data not shown). These
results confirm that observed at small-scale level (Fig. 2A)
and indicate that the fragility at the linker position is not
a specificity of the GST fusions [11]. Similar degradation
products also occur in large scale screening experiments
performed using GFP, GST, Trx, MBP as fusion partners
[17]. What we observed with other proteins is that the
degree of degradation using a specific vector varies from
negligible levels to almost 100% [11], suggesting that is
the specific interaction carrier-target protein to determine
the fragility of the construct rather than the carrier itself.
Our results give an indication of how much the length and
composition of the expressed non-native N-terminus
domain (His-tag/linker/protease recognition sequence)
influence the stability of the expressed constructs. The sol-
ubility and yields of EYFP recovered from bacteria trans-
formed with pRSET and pETM11 were low (0.4 mg/mL
and Fig. 2; 1.1 mg/L, Table 2) in comparison to EYFP from
pETM10 and 14 (more than 10 mg/L, Table 2). The EYFP
construct expressed from pRSET has a 33 aa tail at the N-
terminus, that of pETM11 has 26 extra aa while the EYFP
Table 2: Yields calculated after large-scale purification and stability of the wild type EYFP fusion proteins generated using the different 
pETM expression vectors. Three different aggregation tests were performed (see M & M) and the symbols indicate: aggregation (+), no 
aggregation (-), not performed (/).
Constructs Soluble fusion protein yield (mg/
Lculture)
Aggregation tests
EYFP-10 11.5 ---
EYFP-11 1.1 -++
EYFP-14 13.8 ---
EYFP-20 2.7 ---
EYFP-22 4.9 ---
EYFP-30Gluthatione 16.6 ---
EYFP-30His 23.3 ---
EYFP-33His 18.7 ---
EYFP-44 4.2 ---
EYFP-50 0 /
EYFP-52 26.8 ---
EYFP-54 0 /
EYFP-55 23.1 ---
EYFP-60 42.2 ---
EYFP-66 40.8 ---
EYFP-70 0 /
EYFP-80 0 /
EYFP-82 1.4 +++Microbial Cell Factories 2005, 4:34 http://www.microbialcellfactories.com/content/4/1/34
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from pETM14 has only 18 aa and the one from pETM10
has as few as 9. Furthermore, the pETM14 linker has more
flexible glycine residues and less large aa than the linker in
pETM11. EYFP obtained after proteolytic digestion of any
of the fusion constructs was soluble and stable, indicating
that the destabilizing effect was specifically due to the
extra non-native amino acids at the N-terminal.
A possible explanation for the poor results obtained using
the cytoplasmic DsbC-EYFP construct from pETM82
would take into consideration the enzymatic activity of
the fusion partner. In fact, DsbC has been shown to be
capable of catalyzing the formation of disulfide bonds
even in the reducing cytoplasm [8] whilst their formation
seems incompatible with a stable structure of EYFP.
We were also interested in comparing some other param-
eters. The position of the His-tag at the N-terminus (GST
and MBP fusions, Table 1) did not apparently improve the
recovery of the recombinant fusions during the affinity
purification. In fact, the yields of constructs in which the
His-tag is expressed in the theoretical less accessible
between the fusion partner and the EYFP -as for NusA and
DsbA fusions- were comparable (Table 2) and no more
unbound recombinant protein was detected in the flow-
through and wash fractions (data not shown).
We also used the double tagged GST-EYFP to compare the
purification efficiency of ion metal affinity for 6xHis and
glutathione sepharose for GST. The yield of the fusion
purified using the His-tag was slightly higher (Table 2) but
Comparison of the protease efficiency of TEV and C3 Figure 3
Comparison of the protease efficiency of TEV and C3. A) The Trx-EYFP fusion protein recovered using the pETM20 and 
pETM22 vectors was digested in the presence of 1 µg (TEV) and 0.2 µg (C3) protease for 100 µg of fusion protein. B) The Trx-
EYFP constructs resuspended in different buffers were digested at 30°C for 3 h in the presence of 1:100 (TEV) and 1:500 (3C) 
diluted proteases.
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the higher affinity for GST using glutathione-sepharose
resulted in less non-specific impurities. The amount of
contaminants due to degradation was in the same propor-
tions (data not shown).
Specificity of the protease cleavage site
The protease recognition sequence had no significant
influence on the protein solubility. In fact, the constructs
expressed by the TEV and 3C versions of the same vectors
(pETM20 and 22, 30 and 33, 60 and 66) gave similar
yields (Table 2). The cleavage efficiency of TEV and 3C
was compared using EYFP-Trx fusions from pETM20 and
22 as substrates. Both proteases cleaved more than 95% of
their substrates after incubation at 30°C for 2 h (Fig. 3A).
Nevertheless, 3C could be used 5 times more diluted than
TEV, namely 2 µg of protease for mg of substrate instead
of 10 µg. Furthermore, 3C was confirmed to be more
active than TEV at 4°C (Figure 3A and [16]). The smaller
mass of 3C in comparison to TEV could lead to a
decreased steric hindrance and allow the facilitated access
to the recognition site [22]. Otherwise, both proteases
remained active in buffers containing up to 500 mM
NaCl, 250 mM imidazole, and 4 mM DTT (Fig. 3B). 3C
was more sensitive to detergents (Triton X-100 and Brij
58) than TEV but less pH-dependent. Most of the combi-
nations of salt, detergent and imidazole had no synergic
inhibitory effect (Fig. 3B). In conclusion, the choice of
either of the two proteases allows the selection of a cleav-
age buffer which is at least partially optimized for the sta-
bility of the substrate protein.
Conclusion
Comparison of the yields of the purified EYFP constructs
from the different expression vectors indicated that
fusions with NusA and GST, as well as constructs with His-
tags and short linkers, resulted in the highest yields of sol-
uble recombinant protein. Furthermore, we did not
observe better affinity binding using constructs with a His-
tag at the N-terminus than with constructs with an inter-
nal tag and the His-GST-EYFP was purified at similar
quantitative and qualitative levels using any of the two
affinity tags. The analysis of the aggregation state of the
purified proteins showed that most of the constructs were
both soluble and monodisperse [23].
The solubilizing effect of the different tags has often been
reported but independent experiments are difficult to
compare because they were performed using a great vari-
ety of growth and detection conditions and often with a
limited number of test proteins [6,24,25]. More system-
atic investigations [17] and our experience involving the
expression of hundreds of proteins using pETM vectors
suggest that the best tag and growth conditions are protein
specific. Therefore, the aim is not the identification an
improbable ideal tag that always ensures better solubility
to any fused passenger protein but to develop strategies
for fast and easy screening among different vectors before
starting the large-scale production. The pETM collection
facilitates the sub-cloning and simplifies the result com-
parison. With respect to other modular systems used in
high throughput proteomics and based on ligation inde-
pendent cloning [26] and recombination [27,28] rather
than classical cloning, the pETM vectors can provide
shorter extra sequences at both protein termini. The nega-
tive effect of extra amino acids and poorly structured
regions on the protein solubility has been related to their
length and composition [29-33] and confirmed by our
experiments performed with the constructs expressed by
pRSET, pETM10, 11, and 14. Finally, the pETM vectors
offer the choice of the specific protease for removal of the
tags thus widening the opportunity to select buffer condi-
tions more compatible with the stability of the target pro-
tein (Fig. 3).
Methods
Cloning into the pETM vectors
Two EYFP (Yellow Fluorescent Protein, AAU85108)
sequences (wild type and mutant I48A) cloned into
pRSET (Invitrogen) were used as a template for the PCR
reactions. The PCR primers were designed to contain the
NcoI restriction site (forward) and either the EcoRI or the
NotI (reverse). Two series of pETM vectors [18] were
digested with NcoI/EcoRI and NcoI/NotI, respectively,
and the digested PCR products were ligated both over-
night and by quick-ligation. The four parallel ligation
products for each vector were used to transform DH5α
competent cells and the highest efficiency was obtained
using the combination NcoI/EcoRI and overnight liga-
tion. After plasmid amplification and sequencing, the
pETM expression vectors containing the sequence-verified
EYFP insert were transformed in BL21 (DE3) competent
cells and the colonies used to inoculate 3 mL of LB for pre-
paring bacterial glycerol stocks and material for the small-
scale screening.
Bacterial culture and protein purification
The bacteria were grown at 37°C until they reached an
OD600 of 0.4, the temperature was then decreased to
20°C, the recombinant expression induced with 0.1 mM
IPTG at an OD600 of 0.6 and the pellet corresponding to
1.5 mL was recovered after overnight culture and stored at
-20°C. Frozen pellets were resuspended in 350 µ L of 20
mM TrisHCl buffer, pH 8.0, (metal affinity purification)
or 350 µ L of 20 mM PBS buffer, pH 7.3, (glutathione
sepharose purification) containing 5 mM MgCl2 1 mM
PMFS, 1 mg/mL lysozyme, and 1 µ g/mL DNase. NaCl was
added to the Tris buffer to a final concentration of 300
mM. The samples were sonicated for 5 min in a water bath
and the total lysate samples were taken before centrifuga-
tion at 5,000 g for 10 min. The resulting supernatantsMicrobial Cell Factories 2005, 4:34 http://www.microbialcellfactories.com/content/4/1/34
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were added to either 25 µ L of Talon beads (Clontech)
equilibrated in 20 mM Tris buffer, 300 mM NaCl, or 25 µ
L glutathione Sepharose 4 Fast Flow resin suspension
(Amersham) equilibrated in 20 mM K-phosphate buffer,
150 mM NaCl, respectively. After incubation with shaking
at room temperature for 30 min the affinity matrixes were
recovered by a short centrifugation and the supernatant
discarded. The glutathione sepharose resin was resus-
pended in PBS, washed for 30 min, recovered as above
and then washed again before being resuspended in 25 µ
L of SDS-PAGE loading buffer. The Talon beads were
washed twice for 30 min in 20 mM Tris-HCl, pH 8.0, 500
mM NaCl, 20 mM imidazole and finally recovered in 25
µ L of SDS-PAGE loading buffer. The purified proteins
were visualized by SDS PAGE.
The purification protocols were modified at the following
steps when large-scale purifications were performed. Pel-
lets from 1L bacterial culture were re-suspended in 4 vol-
umes of buffer (PBS + 5 mM MgCl2 and 1 mM PMFS or 20
mM TrisHCl buffer, pH 8.0, 500 mM NaCl, 10 mM imida-
zole 5 mM MgCl2 and 1 mM PMFS) and sonicated 5 min
in a water bath. 1 mg/mL lysozyme and 1 µ g/mL DNase
were added and the lysates were incubated with shaking at
room temperature for 30 min. The samples were centri-
fuged at 90.000 × g for 35 min, the supernatants filtered
and loaded onto a pre-equilibrated GSTrap or Hi-Trap
chelating columns (Amersham) charged with CoCl2,
respectively, connected to a FPLC system. The elution was
performed using either 25 mM Tris HCl, pH 8.0, 10 mM
reduced glutathione (glutathione affinity) or 20 mM Tris
HCl, pH 8.0, 250 Mm imidazole (IMAC). The purified
proteins were buffer exchanged into 50 mM PBS contain-
ing 10% glycerine using a HiTrap Desalting column
(Amersham), the protein concentration was calculated
after measurement of the absorbance at 280 nm, and sam-
ples were prepared for SDS-PAGE.
Protein aggregation analysis and protease activities
Protein aggregation was measured according to Nominé
et al. [34] using a luminescence spectrometer (SLM
Aminco). The stability of the purified constructs was
determined by comparing the aggregation index calcu-
lated using fresh samples (control) with: a) samples
thawed after incubation at -80°C for 24 hours, b) samples
frozen and thawed for 5 cycles, c) incubated at 30°C for
24 hours.
Protein gels were stained using SimplyBlue Safe Stain
(Invitrogen) and the relative protein content in each band
quantified using the public domain NIH Image program
(developed at the U.S. National Institutes of Health [35]).
TEV and 3C proteases were used at concentrations varying
from 1:100 to 1:1000 dilutions with respect to the sub-
strate, at 4 and 30°C, and using 2 or 18 hour incubation.
The different buffers are indicated in the legend to the Fig-
ure 3.
Additional File 1. (PDF) "The maps of the pETM vectors".
The maps and the MCS regions of the pETM vectors used
in the experiments are reported.
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